Mycophenolate Mofetil

CellCept, MYHIBBIN, Mycophenolate Mofetil

Immunosuppressant

NADAC/unit $0.1403

No Shortage Tier 1: 64.4% PA Req: 331.9% 24 Manufacturers 36 ANDAs

vs. brand CellCept: Generic saves up to 99% per unit

Covered Lives

Market Intelligence

2023-11-15 Class III Recall: VistaPharm LLC

Generic Manufacturers

ACCORD HEALTHCARE INCALKEM LABORATORIES LTDAMNEAL PHARMACEUTICALS LLCAUROBINDO PHARMA LTDAZURITY PHARMACEUTICALS INCBPI LABS LLCCONCORD BIOTECH LTDHETERO LABS LTD UNIT VHIKMA PHARMACEUTICALS USA INCLANNETT CO INCMEITHEAL PHARMACEUTICALS INCMYLAN LABORATORIES LTDMYLAN PHARMACEUTICALS INCONESOURCE SPECIALTY PTE LTDPH HEALTH LTDRISING PHARMA HOLDING INCRISING PHARMA HOLDINGS INCROCHE PALO ALTO LLCSANDOZ INCSTRIDES PHARMA GLOBAL PTE LTDSTRIDES PHARMA INTERNATIONAL AGTEVA PHARMACEUTICALS USAVISTAPHARM LLCWUXI FORTUNE PHARMACEUTICAL CO LTDZHEJIANG HISUN PHARMACEUTICAL CO LTDZYDUS PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Mycophenolate Mofetil drfinder.aiFind doctors who prescribe Mycophenolate Mofetil clinicalrx.aiClinical profile: Mycophenolate Mofetil rxnews.aiLatest news about Mycophenolate Mofetil

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.